Avadel Pharmaceuticals (AVDL) EPS (Basic) (2016 - 2020)
Historic EPS (Basic) for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q4 2020 value amounting to -$0.04.
- Avadel Pharmaceuticals' EPS (Basic) rose 9639.38% to -$0.04 in Q4 2020 from the same period last year, while for Dec 2020 it was $0.12, marking a year-over-year increase of 10600.51%. This contributed to the annual value of -$0.12 for FY2020, which is 9413.32% up from last year.
- Latest data reveals that Avadel Pharmaceuticals reported EPS (Basic) of -$0.04 as of Q4 2020, which was up 9639.38% from -$0.2 recorded in Q3 2020.
- Over the past 5 years, Avadel Pharmaceuticals' EPS (Basic) peaked at $0.7 during Q2 2017, and registered a low of -$1.71 during Q4 2018.
- Over the past 5 years, Avadel Pharmaceuticals' median EPS (Basic) value was -$0.2 (recorded in 2017), while the average stood at -$0.19.
- In the last 5 years, Avadel Pharmaceuticals' EPS (Basic) surged by 52000.0% in 2017 and then crashed by 73923.77% in 2018.
- Avadel Pharmaceuticals' EPS (Basic) (Quarter) stood at $0.11 in 2016, then plummeted by 277.54% to -$0.2 in 2017, then crashed by 739.24% to -$1.71 in 2018, then rose by 28.8% to -$1.22 in 2019, then soared by 96.39% to -$0.04 in 2020.
- Its last three reported values are -$0.04 in Q4 2020, -$0.2 for Q3 2020, and $0.57 during Q2 2020.